A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer

Clinical Trial ID NCT01095848

PubWeight™ 5.04‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01095848

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Liposomes as nanomedical devices. Int J Nanomedicine 2015 1.29
2 Trial watch: Peptide vaccines in cancer therapy. Oncoimmunology 2012 1.17
3 Immunotherapy in ovarian cancer. Hum Vaccin Immunother 2012 0.99
4 First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J Transl Med 2012 0.96
5 Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother 2014 0.89
Next 100